1. Home
  2. ARCT vs SCM Comparison

ARCT vs SCM Comparison

Compare ARCT & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.04

Market Cap

245.4M

Sector

Health Care

ML Signal

HOLD

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

HOLD

Current Price

$9.08

Market Cap

267.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCT
SCM
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
245.4M
267.2M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
ARCT
SCM
Price
$7.04
$9.08
Analyst Decision
Buy
Hold
Analyst Count
10
1
Target Price
$24.11
$9.00
AVG Volume (30 Days)
402.0K
129.7K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
14.22%
EPS Growth
20.00
N/A
EPS
N/A
0.06
Revenue
$82,031,000.00
N/A
Revenue This Year
N/A
$0.33
Revenue Next Year
$12.77
N/A
P/E Ratio
N/A
$151.50
Revenue Growth
N/A
N/A
52 Week Low
$5.85
$8.43
52 Week High
$24.14
$15.39

Technical Indicators

Market Signals
Indicator
ARCT
SCM
Relative Strength Index (RSI) 37.07 37.97
Support Level $6.90 $8.80
Resistance Level $7.88 $9.85
Average True Range (ATR) 0.61 0.28
MACD -0.21 -0.05
Stochastic Oscillator 12.86 17.92

Price Performance

Historical Comparison
ARCT
SCM

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.

Share on Social Networks: